Рет қаралды 893
EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person is a comprehensive guidebook for clinicians that presents a novel therapeutic framework for administering psychedelic medicines. The EMBARK model was developed in response to the growing interest in psychedelic medicines for treating mental health disorders, particularly depression, and the identified gaps in existing models of psychedelic-assisted therapy (PAT).
Alex Belser, PhD, is a clinical scientist, author, and licensed psychologist with a focus on psychedelic research. Currently he is At Yale University working as a Co-Investigator for a study investigating psilocybin treatment for people with OCD. He has explored the potential of novel therapies in multiple clinical trials with psilocybin, MDMA, ketamine, and DMT to help alleviate symptoms of depression, anxiety, addiction, and PTSD.
Learn more and earn continuing education (CE) credits: psychedelic.support/